Results 211 to 220 of about 543 (229)
Some of the next articles are maybe not open access.
SLEEP
Abstract Introduction In a disproportionality analysis (Merino D, et al. J Clin Med. 2022;11:3890), sodium oxybate (SXB) treatment was associated with sleep-related eating disorder (SRED), a parasomnia characterized by somnambulism and compulsive eating. Immediate-release twice-nightly oxybate (TN-OXB)
openaire +1 more source
Abstract Introduction In a disproportionality analysis (Merino D, et al. J Clin Med. 2022;11:3890), sodium oxybate (SXB) treatment was associated with sleep-related eating disorder (SRED), a parasomnia characterized by somnambulism and compulsive eating. Immediate-release twice-nightly oxybate (TN-OXB)
openaire +1 more source
SLEEP
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) demonstrated efficacy in treating narcolepsy symptoms, including disrupted nighttime sleep (DNS), in the phase 3 REST-ON trial (NCT02720744). This post hoc analysis assessed ON-SXB efficacy on DNS across various participant subgroups.
Yves Dauvilliers +7 more
openaire +1 more source
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) demonstrated efficacy in treating narcolepsy symptoms, including disrupted nighttime sleep (DNS), in the phase 3 REST-ON trial (NCT02720744). This post hoc analysis assessed ON-SXB efficacy on DNS across various participant subgroups.
Yves Dauvilliers +7 more
openaire +1 more source
SLEEP
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) is an extended-release formulation of sodium oxybate that eliminates the second, middle-of-the-night dose required by immediate-release twice-nightly oxybate (TN-OXB) formulations.
Sally Ibrahim +7 more
openaire +1 more source
Abstract Introduction Once-nightly sodium oxybate (ON-SXB; LUMRYZ™) is an extended-release formulation of sodium oxybate that eliminates the second, middle-of-the-night dose required by immediate-release twice-nightly oxybate (TN-OXB) formulations.
Sally Ibrahim +7 more
openaire +1 more source
SLEEP
Abstract Introduction Narcolepsy is a chronic neurologic condition of excessive daytime sleepiness (EDS), disturbed nocturnal sleep, and REM dissociation. In 2002, Xyrem (sodium oxybate) was approved by the U.S Food and Drug Administration (FDA) for treatment of EDS and cataplexy in narcolepsy.
Gerard Meskill +3 more
openaire +1 more source
Abstract Introduction Narcolepsy is a chronic neurologic condition of excessive daytime sleepiness (EDS), disturbed nocturnal sleep, and REM dissociation. In 2002, Xyrem (sodium oxybate) was approved by the U.S Food and Drug Administration (FDA) for treatment of EDS and cataplexy in narcolepsy.
Gerard Meskill +3 more
openaire +1 more source
The New Zealand medical journal, 1988
Sixty-nine patients with symptomatic and endoscopically diagnosed gastric or duodenal ulcers received treatment with either pirenzepine 100 mg or cimetidine 800 mg one hour before bedtime in a prospective randomised, double blind study. Fifty-five patients completed the six weeks treatment period of whom 13/15 (87%) gastric ulcers and 13/16 (81 ...
D P, Edge, P, Brown, K, Luey, N H, Stace
openaire +1 more source
Sixty-nine patients with symptomatic and endoscopically diagnosed gastric or duodenal ulcers received treatment with either pirenzepine 100 mg or cimetidine 800 mg one hour before bedtime in a prospective randomised, double blind study. Fifty-five patients completed the six weeks treatment period of whom 13/15 (87%) gastric ulcers and 13/16 (81 ...
D P, Edge, P, Brown, K, Luey, N H, Stace
openaire +1 more source
Long-Term Safety of Once-Nightly Sodium Oxybate: Interim Analysis of Data From RESTORE (P5-13.005)
Neurology, 2023Thomas Stern +8 more
openaire +1 more source
Once nightly sustained release theophylline in elderly subjects.
British journal of clinical pharmacology, 1989P, Coates, J, McKellar, A J, Miller
openaire +1 more source
Once nightly sustained release theophylline in elderly subjects.
British journal of clinical pharmacology, 1988A, Rodgers, K W, Woodhouse, D N, Bateman
openaire +2 more sources